U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ABAGOVOMAB
3YK0326U7X
Investigational
General
Names
5
Classification
3
Identifiers
7
Subunits
4
Related Substances
1
ABAGOVOMAB
3YK0326U7X
Investigational
General
Approval Year
Unknown
139,594
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ABAGOVOMAB
Official Name
English
abagovomab [INN]
Common Name
English
ACA-125
Code
English
MEN-2234
Code
English
Abagovomab [WHO-DD]
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Antineoplastic Vaccine
Pharmacologic Substance
[C1909]
Antineoplastic Agent
[C274]
Antineoplastic Vaccine
[C1663]
Anti-Idiotype Vaccine
NCI_THESAURUS
C2590
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of epithelial ovarian cancer
FDA ORPHAN DRUG
171803
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
WIKIPEDIA
ABAGOVOMAB
PRIMARY
ChEMBL
CHEMBL1742981
PRIMARY
CAS
792921-10-9
PRIMARY
FDA UNII
3YK0326U7X
PRIMARY
INN
8659
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
3YK0326U7X
ABAGOVOMAB